Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Mauritius.
Press releases published on October 21, 2025
Qinary Unveils Innovative AI Search Blueprint for Market Leadership
Scottsdale, Arizona, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Qinary, a pioneering force in next-generation marketing systems, is proud to announce a groundbreaking initiative led by its CEO, Buck Wise. This new venture is set to revolutionize how entrepreneurs …
Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series
SAN CARLOS, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in Citi’s SMID Biotech C-Suite Fireside Chat Series on Thursday, …
Rocket Doctor AI Engages Fundamental Research Corp. for Analyst Coverage
Vancouver, BC, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that we have engaged Fundamental Research Corp. (“FRC”), an independent small-cap research firm, for analyst …
DeLeion Capital Launches Innovative Digital Asset Management Plans for Bitcoin, Ethereum, and XRP
Washington, USA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- DeLeion Capital, a leading digital asset management company specializing in blockchain-based investment strategies, today announced the launch of its new suite of asset management plans designed for …
Enovix to Release Third Quarter 2025 Financial Results on November 5, 2025
FREMONT, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced it will release financial results for the third quarter on Wednesday, November 5, …
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
ROCKVILLE, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …
IGEL and Asc3nd Collaborate with Cisco, the National Defense University1 to Accelerate DoW Comply-to-Connect and Zero Trust Mission Readiness
FORT LAUDERDALE, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- IGEL, the global leader in endpoint security and provider of the IGEL Secure Endpoint OS Platform™ for now and next, today announced the successful completion of a joint initiative in collaboration …
VDE Americas Goes Global to Meet Rising Demand for Hail Risk Intelligence
SAN JOSE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- VDE Americas, a global leader in technical advisory and catastrophic risk assessment services for the solar industry, today announced the internationalization of its innovative hail risk assessment and …
Teva und Prestige Biopharma schließen Lizenzvereinbarung für die Vermarktung von Tuznue® in Europa
Teva und Prestige geben eine Lizenz- und Liefervereinbarung für die Vermarktung des von Prestige hergestellten Arzneimittels Tuznue® bekannt, einem Biosimilar zu Herceptin® (trastuzumab) Die Europäische Kommission (EK) erteilte Tuznue® im September 2024 …
Teva et Prestige Biopharma concluent un accord de licence pour la commercialisation de Tuznue® en Europe
Teva et Prestige annoncent un accord de licence et d’approvisionnement pour la commercialisation de Tuznue®, un biosimilaire d’Herceptin® (trastuzumab) produit par Prestige Tuznue® a reçu l’autorisation de mise sur le marché de la Commission européenne (CE …
Pala Casino Spa Resort Successfully Upgrades to QCI’s Latest Enterprise Platform, AGI56
SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), a global leader in AI-driven analytics and operational intelligence for casinos and resorts, announced today that Pala Casino Spa Resort has successfully completed its upgrade to …
DeLeion Capital Launches Ethereum Digital Asset Custody Service Amid Market Uncertainty — Offering a Secure Path
Florida City, Oct. 21, 2025 (GLOBE NEWSWIRE) -- In the wake of growing political and economic uncertainty in the United States, DeLeion Capital, a leading global digital asset management firm, has announced the official launch of its Ethereum (ETH) …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
AvePoint to Announce Third Quarter 2025 Financial Results on November 6
JERSEY CITY, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX: AVP), the global leader in data security, governance, and resilience, will report its third quarter 2025 financial results after the US financial markets close on Thursday, …
Inspired to Report Third Quarter 2025 Results and Hold Conference Call on November 5
NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. ("Inspired" or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware and services, announced that it will report financial results for the …
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
WOODCLIFF LAKE, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the voting results for each of the matters presented at the Company’s 2025 annual meeting of stockholders …
Inotiv, Inc. to Participate in Three Investor Conferences in November 2025
WEST LAFAYETTE, Ind., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …
NurExone Invited Presenter at Precision EV Forum in Cambridge, UK
TORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a biopharmaceutical company developing exosome-based regenerative therapies, announced that Dr. Ina …
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients …
Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will …